Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03886961 · ClinicalTrials.gov registry record · NA
The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients
A NA study of GERD and Lung Transplant, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03886961: Recruiting NA study of GERD and Lung Transplant, sponsored by University of Florida.
NCT03886961 is a NA study of GERD and Lung Transplant that is actively recruiting participants, run by University of Florida. The registered enrollment target is 20 participants, below the 166-participant average among 15 other GERD trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03886961, a NA study of GERD and Lung Transplant, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective, open label, study designed to assess the affect of the Reflux Band® UES Assist Device (Reflux Band) on reflux in patients that have undergone lung transplantation.
Primary Outcome
The presence of reflux will be assessed by measuring levels of pepsin in bronchoalveolar lavage fluid.
Conditions Studied
Interventions
- DEVICE Reflux Band
Study Locations (1)
Florida
- UF Health at the University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-05-17 |
| Est. Completion | 2027-12-20 |
| Phase | NA |
What NCT03886961 shows while recruiting
NCT03886961 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 166-participant average among 15 other GERD trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with GERD appearing as the primary indexed condition, and to 1 intervention - of which Reflux Band is the first listed.
NCT03886961 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03886961 about?
NCT03886961 is a clinical study titled "The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients". A prospective, open label, study designed to assess the affect of the Reflux Band® UES Assist Device (Reflux Band) on reflux in patients that have undergone lung transplantation.
What is the current status of trial NCT03886961?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2019-05-17. Estimated completion is 2027-12-20.
What conditions does trial NCT03886961 study?
This clinical trial studies the following conditions: GERD, Lung Transplant.
What interventions are being tested in trial NCT03886961?
The interventions under investigation include: Reflux Band (DEVICE).
Who is sponsoring clinical trial NCT03886961?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03886961 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for GERD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03886961's enrollment target sits among peer trials
20 14th of 15 higher than 1 of 15 other GERD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other GERD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mesh Vs Pledgets for Repair of Paraesophageal Hernia
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Truncal Vagotomy in Patients Undergoing Revisional Sleeve Gastrectomy to Gastric Bypass
RECRUITING · NA
-
Mechanisms Preventing Pharyngeal Reflux
RECRUITING · NA
-
Gracie Diet for Gastroesophageal Reflux Disease
ACTIVE NOT RECRUITING · NA
-
Multicenter Single-Blind RCT of CTIF Versus LNF For Treatment of GERD in Patients Requiring Hiatal Hernia Repair
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI